Gland Pharma Limited

NSE:GLAND.NS

1810.05 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

20232022202120202019201820172016
Assets:
Current Assets:
Cash & Cash Equivalents 18,394.3219,088.953,158.244,918.21,694.972,364.023,728.415,330.77
Short Term Investments 17,342.7819,273.0129,268.9319,546.8511,427.284,843.452,782.990
Cash and Short Term Investments 18,394.3238,361.9632,427.1724,465.0513,122.257,207.476,511.45,330.77
Net Receivables 15,586.98,715.3312,514.6612,726.787,767.325,520.485,307.934,178.73
Inventory 16,552.3719,45311,856.6712,751.687,562.799,118.765,128.33,787.19
Other Current Assets 5,917.932,477.791,722.291,292.9110.547,248.335,681.93784.81
Total Current Assets 56,451.5269,008.0858,520.7951,236.4228,462.923,574.5617,321.6314,081.5
Non-Current Assets:
Property, Plant & Equipment, Net 38,301.5217,361.0317,268.9713,244.4211,969.0210,950.2610,464.6710,327.31
Goodwill 2,422.590000000
Intangible Assets 1,122.19116.61125.3500000
Goodwill and Intangible Assets 3,544.78116.61125.3500000
Long Term Investments 6,559.13-733.662,000-19,477.3316.6113.2819.50
Tax Assets 504.37958.88-415.0500000
Other Non-Current Assets 1,251.141,064.41836.1519,957.31411.86697.391,488.88328.64
Total Non-Current Assets 50,160.9418,767.2719,815.4213,724.412,397.4911,660.9311,973.0510,655.95
Total Assets 106,612.4687,775.3578,336.2164,960.8240,860.3935,235.4929,294.6824,737.45
Liabilities & Equity:
Current Liabilities:
Account Payables 8,626.925,873.54,628.54,007.252,490.944,461.982,918.111,892.89
Short Term Debt 2,309.477.092.612.9710.176.25.084.6
Tax Payables 516.379.85179.79286.9107.23110.041290
Deferred Revenue 516.37486.08636.571,051.81917.95741.64830.010
Other Current Liabilities 2,530.87924.66552.5763.25171.17117.8738.69636.35
Total Current Liabilities 13,983.637,291.335,820.255,125.283,590.235,327.693,791.892,533.84
Non-Current Liabilities:
Long Term Debt 1,065.437.4444.8246.9849.9460.1166.359.16
Deferred Revenue Non-Current 346.7949.9455.5456.6758.02201.6100
Deferred Tax Liabilities Non-Current 2,201.23842.03877.6738.81740.541,075.69957.140
Other Non-Current Liabilities 1,776.98-32.61-38.21-39.34-40.69-49.6375.761,246.34
Total Non-Current Liabilities 5,390.4896.8939.75803.12807.811,287.811,399.21,305.5
Total Liabilities 19,374.038,188.136,7605,928.44,398.046,615.55,191.093,839.34
Equity:
Preferred Stock 015.59000000
Common Stock 164.71164.7164.3163.59154.95154.95154.95154.95
Retained Earnings 67,878.4860,153.8852,343.4540,226.8130,257.1822,527.4618,008.915,579.26
Accumulated Other Comprehensive Income/Loss 87,073.72-15.59114.54240.93160.2847.6449.814.18
Other Total Stockholders Equity -67,878.4819,268.6418,953.9218,401.095,889.945,889.945,889.945,149.72
Total Shareholders Equity 87,238.4379,587.2271,576.2159,032.4236,462.3528,619.9924,103.5920,898.11
Total Equity 87,238.4379,587.2271,576.2159,032.4236,462.3528,619.9924,103.5920,898.11
Total Liabilities & Shareholders Equity 106,612.4687,775.3578,336.2164,960.8240,860.3935,235.4929,294.6824,737.45